A Diagnostic Dilemma: Persistent Fever in a Hospitalized Patient With Alcohol Use Disorder and Pneumonia

诊断难题:酒精使用障碍合并肺炎住院患者持续发热

阅读:1

Abstract

Hospitalized patients with alcohol use disorder (AUD) frequently pose diagnostic and therapeutic challenges due to the interplay of substance use, withdrawal, and coexisting medical conditions. This case presents a 49-year-old man with a history of chronic alcohol overuse and previous alcohol withdrawal seizures, admitted for a right middle lobe pneumonia. Initial management included empiric antibiotics, hydration, and nutritional supplementation. He was also placed on symptom-triggered benzodiazepine therapy, guided by the Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) protocol, to manage alcohol withdrawal. Despite the broad-spectrum antibiotic coverage, the patient continued to experience fever and tachycardia, raising concerns about an atypical infectious process versus the manifestation of severe alcohol withdrawal. Further consideration and evaluation ruled out antibiotic-resistant organisms, pneumonia-related complications, and alternative infections such as urinary tract infection, meningitis, and endocarditis. Blood cultures taken on admission remained persistently negative, and procalcitonin levels were significantly down-trending, indicating the resolution of a bacterial infectious etiology. By hospital day 3, the patient began exhibiting agitation, shakiness, and confusion, along with persistent spikes in temperature, heart rate, and blood pressure, raising strong suspicion for delirium tremens (DT). This necessitated escalating benzodiazepine dosage on the CIWA-Ar protocol. By hospital day 9, the patient's symptoms had largely resolved, and he was discharged with ongoing care for AUD and follow-up for a lung nodule incidentally identified on chest imaging. This case emphasizes the need for a systematic diagnostic approach to differentiate overlapping symptoms in AUD patients, particularly in the context of acute infections and withdrawal syndromes. Early recognition and aggressive management of DT are critical to prevent complications and improve outcomes in this high-risk population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。